Itamar Medical Ltd has entered into an agreement with Sleep Data Diagnostics and its virtual-care platform BetterNight and Sleep Data Holdings, a provider of home-based positive airway pressure services. This agreement is designed to simplify the process by which both sleep and non-sleep referring physicians, such as cardiologists, can refer their patients for sleep apnea testing with WatchPAT through Itamar Medical and BetterNight’s platforms providing a full care pathway that includes testing, medical consultation, continuous positive airway pressure (CPAP) therapy, billing and reimbursement channels.
Itamar Medical and BetterNight will collaborate to provide physicians and their patients a fully integrated and streamlined solution. Itamar Medical will provide patients suspected of having sleep apnea with a sleep apnea diagnostic study, facilitate a consultation with a board-certified physician for study interpretation and receipt of a prescription for a recommended therapy, if needed, enabled by its digital health platform. When elected by the managing physician, BetterNight will provide home-based CPAP therapy care using its monitoring algorithm and remote respiratory therapy consultation and manage insurance coverage verification, preauthorization, and billing.
“Physicians, particularly cardiologists, are aware of the negative effects sleep disordered breathing can have on their patients. However, they face a variety of hurdles to ensuring that patients undergo testing and receive appropriate treatment. This is even more challenging today due to the COVID-19 pandemic as so many patients must stay at home and access to in-lab testing is limited,” says Gilad Glick, president and CEO of Itamar Medical, in a release. “This agreement demonstrates our commitment in working with leaders across the sleep apnea ecosystem to add home care options for sleep apnea management and addressing the global sleep apnea epidemic.”
Dave French, Sleep Data CEO, says, “BetterNight is a leader in providing comprehensive sleep solutions that have the potential to make a positive impact on the millions of people living with sleep disorders. Adding WatchPAT’s innovative technology, as well as the Itamar Digital Health platform, will be a key component of our sleep apnea solution.”
Dominic Munafo, MD, DABSM, chief medical officer of BetterNight, says, “Sleep is vitally important to a patient’s health, restoring their immune system, lessening the impact of chronic disease and improving their ability to fight infection. It is crucial to pioneer safe and innovative ways to address the sleep health needs of patients during the COVID-19 pandemic. WatchPAT ONE allows patients to access highly accurate and data-rich sleep apnea testing from the comfort of their homes, eliminating the barriers associated with overnight testing at a sleep clinic and reducing infection risk. Our sleep specialist staff uses multiple WatchPAT signals to provide rapid and accurate diagnoses, allowing those patients who need CPAP therapy to receive their CPAP devices and coaching in a timely manner. We are excited to collaborate with Itamar Medical in bridging the gap between a cardiologist’s sleep study referral and effective therapy.”